Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The airway mucociliary apparatus, commonly known as the mucociliary escalator, is a vital physiological system that serves as the primary defense mechanism for the respiratory tract by clearing inhaled particles and pathogens [StatPearls: Physiology, Mucociliary Clearance]. It consists of a coordinated interaction between the mucus-producing goblet cells, the ciliated epithelial cells, and the periciliary liquid layer that facilitates ciliary movement [Bustamante-Marin & Ostrowski, 2017, Cold Spring Harb Perspect Biol]. In a healthy state, the rhythmic beating of cilia propels a layer of trapped debris toward the pharynx for elimination [NIH: PubMed Central, PMC5378498]. Dysfunction of this apparatus is a central feature of several chronic lung diseases, including cystic fibrosis, where mucus becomes dehydrated and stagnant, and primary ciliary dyskinesia, where ciliary motility is genetically impaired [Mall, 2008, J Physiol]. Therapeutic interventions targeting this system aim to restore clearance by modifying mucus rheology, increasing airway surface liquid volume, or enhancing ciliary beat frequency [Rubin, 2007, Paediatr Respir Rev]. Common pharmacological agents include mucolytics like N-acetylcysteine and ion channel modulators like ivacaftor, which indirectly improve the system's function by correcting underlying molecular defects [Boucher, 2007, J Intern Med].
Enhancement of mucociliary clearance through mucus thinning, airway surface liquid hydration, and stimulation of ciliary beat frequency.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway mucociliary apparatus (MCA).